Cargando…
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
OBJECTIVES: Advancements in non-small cell lung cancer treatment based on targeted therapies have made the differentiation between adenocarcinoma and squamous cell carcinoma increasingly important. Pathologists are challenged to make the correct diagnosis in small specimens. We studied the accuracy...
Autores principales: | Bernardi, Fabiola Del Carlo, Bernardi, Marcela Del Carlo, Takagaki, Teresa, Siqueira, Sheila Aparecida Coelho, Dolhnikoff, Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201148/ https://www.ncbi.nlm.nih.gov/pubmed/30379223 http://dx.doi.org/10.6061/clinics/2018/e361 |
Ejemplares similares
-
The Expression of Water and Ion Channels in Diffuse Alveolar Damage Is Not Dependent on DAD Etiology
por: Pires-Neto, Ruy Camargo, et al.
Publicado: (2016) -
Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis
por: Baldi, Bruno Guedes, et al.
Publicado: (2011) -
Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
por: You, Kiho, et al.
Publicado: (2017) -
Cervical Pre-cancers: Biopsy and Immunohistochemistry
por: Kamal, Meherbano
Publicado: (2022) -
Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)